Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q89500629 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241120235753.0 | ||
| 008 | 241120nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q89500629 | ||
| 024 | ‡a 0000-0002-9566-6969 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q89500629 | ||
| 100 | 0 | ‡a Rita Moiron Simões ‡c researcher ‡9 en | |
| 400 | 0 | ‡a Rita Moiron Simões ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's Comments on: 'Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial'. | ||
| 670 | ‡a Author's Inhaled levodopa for intermittent treatment of OFF episodes in patients with Parkinson's disease | ||
| 909 | ‡a (orcid) 0000000295666969 ‡9 1 | ||
| 919 | ‡a commentsonpyridostigminebromideversusfludrocortisoneinthetreatmentoforthostatichypotensioninparkinsonsdiseasearandomizedcontrolledtrial ‡A Comments on: 'Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial'. ‡9 1 | ||
| 919 | ‡a inhaledlevodopaforintermittenttreatmentofoffepisodesinpatientswithparkinsonsdisease ‡A Inhaled levodopa for intermittent treatment of OFF episodes in patients with Parkinson's disease ‡9 1 | ||
| 996 | ‡2 PTBNP|1889345 | ||
| 996 | ‡2 PTBNP|1432645 | ||
| 996 | ‡2 NTA|336379269 | ||
| 996 | ‡2 ISNI|0000000391939517 | ||
| 996 | ‡2 PTBNP|1449785 | ||
| 996 | ‡2 SUDOC|179274384 | ||
| 996 | ‡2 SUDOC|177142782 | ||
| 996 | ‡2 LC|no2008091500 | ||
| 996 | ‡2 ISNI|000000007082994X | ||
| 996 | ‡2 PTBNP|1924315 | ||
| 996 | ‡2 ISNI|0000000067820039 | ||
| 996 | ‡2 ISNI|0000000069398521 | ||
| 996 | ‡2 PTBNP|1289828 | ||
| 996 | ‡2 ISNI|0000000511302327 | ||
| 996 | ‡2 BNF|18082053 | ||
| 996 | ‡2 PTBNP|1584744 | ||
| 996 | ‡2 PTBNP|251582 | ||
| 996 | ‡2 PTBNP|1315856 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
